Pharmacokinetics of Subcutaneous Injection of Testosterone in an Oil Vehicle: A Randomised crossover study of Reandron (Testosterone Undecanoate) given subcutaneously and intramuscularly in hypogonadal men
Phase of Trial: Phase IV
Latest Information Update: 29 Nov 2018
At a glance
- Drugs Testosterone undecanoate (Primary) ; Testosterone undecanoate (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics
- 26 Nov 2018 Status changed from recruiting to completed.
- 19 May 2016 Status changed from not yet recruiting to recruiting.
- 22 Feb 2013 New trial record